Table 1.
Associations between clinicopathological features and the CD169 score
| Characteristics | n | CD169 total score | P‐value | |
|---|---|---|---|---|
| Low (n = 26) | High (n = 18) | |||
| Age | ||||
| <70 | 19 | 10 | 9 | .448 |
| ≥70 | 25 | 16 | 9 | |
| Gender | ||||
| Male | 35 | 21 | 14 | .801 |
| Female | 9 | 5 | 4 | |
| ECOG‐PS | ||||
| 0 | 39 | 25 | 14 | .057 |
| 1 | 5 | 1 | 4 | |
| Pathological T stage | ||||
| T1, T2 | 22 | 9 | 13 | .013a |
| T3, T4 | 22 | 17 | 5 | |
| LN metastasis | ||||
| No | 38 | 23 | 15 | .628 |
| Yes | 6 | 3 | 3 | |
| Neoadjuvant chemotherapy | ||||
| No | 40 | 24 | 16 | .700 |
| Yes | 4 | 2 | 2 | |
| Adjuvant chemotherapy | ||||
| No | 33 | 18 | 15 | .280 |
| Yes | 11 | 8 | 3 | |
| Histological type | ||||
| UC only | 35 | 20 | 15 | .601 |
| Others | 9 | 6 | 3 | |
| CD8+ cells/cm2 in the tumor | ||||
| <343 | 25 | 19 | 6 | .008a |
| ≥343 | 19 | 7 | 12 | |
ECOG‐PS, Eastern Cooperative Oncology Group‐Performance Status; LN, lymph node; UC, urothelial carcinoma.
a
Statistically significant results. The average number of CD8+ cells/mm2 in the tumor is 343.